A novel class of oxazepine-based anti-cancer agents induces cell death in primary human CLL cells and efficiently reduces tumor growth in Eμ-TCL1 mice through the JNK/STAT4/p66Shc axis-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

A novel class of oxazepine-based anti-cancer agents induces cell death in primary human CLL cells and efficiently reduces tumor growth in Eμ-TCL1 mice through the JNK/STAT4/p66Shc axis

Published:2021-12 Issue: Volume:174 Page:105965
ISSN:1043-6618
Container-title:Pharmacological Research
language:en
Short-container-title:Pharmacological Research

Author:

Vanni Francesca,Lopresti Ludovica,Zurli Vanessa,Kabanova Anna,Cattaneo Francesca,Sicuranza Anna,Gozzetti Alessandro,Gemma Sandra,Zisterer Daniela M.,Bocchia Monica,Campiani Giuseppe,Baldari Cosima T.,Butini Stefania,Ulivieri Cristina

Publisher

Elsevier BV

Subject

Pharmacology

Reference47 articles.

1. iwCLL guidelines for diagnosis, indications for treatment, response assessment, and supportive management of CLL;Hallek;Blood,2018

2. For CLL cells, there’s no place like home;Lampson;Leuk. Lymphoma,2019

3. P66shc: a pleiotropic regulator of b cell trafficking and a gatekeeper in chronic lymphocytic leukemia;Patrussi;Cancers,2020

4. Chronic lymphocytic leukaemia;Kipps;Nat. Rev. Dis. Prim.,2017

5. Abnormalities in chemokine receptor recycling in chronic lymphocytic leukemia;Patrussi;Cell. Mol. Life Sci.,2019

Cited by 1 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Preparation, the spectroscopic and biological study of some derivatives of (β-lactam, oxazepine, and imidazole) linked to a heterocyclic nucleus;2ND INTERNATIONAL CONFERENCE OF MATHEMATICS, APPLIED SCIENCES, INFORMATION AND COMMUNICATION TECHNOLOGY;2023

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP